Table 1.
Baseline Demographics of Patients
| MF-DPI 400 μg QD PM (n = 611) |
MF-DPI 200 μg BID (n = 622) |
|
|---|---|---|
| Mean age, y | 50.9 | 50.2 |
| Patients by age, n (%) | ||
| 12 to <18 y | 21 (3) | 22 (4) |
| 18 to <65 y | 444 (73) | 465 (75) |
| ≥65 y | 146 (24) | 135 (22) |
| Sex | ||
| Women/men | 338/273 | 357/265 |
| Race | ||
| White/nonwhite | 607/4 | 615/7 |
| Mean body weight, kg | 77.3 | 76.7 |
| n = 599 | n = 614 | |
| Mean duration of SAR, y | 17.2 | 19.2 |
| n = 238 | n = 235 | |
| Mean duration of PAR, y | 19.7 | 20.9 |
| n = 163 | n = 164 | |
| Mean duration of asthma, y | 16.4 | 16.2 |
| n = 611 | n = 622 |
BID = twice-daily; MF-DPI = mometasone furoate administered via a dry powder inhaler; PAR = perennial allergic rhinitis; QD PM = once-daily in the evening; SAR = seasonal allergic rhinitis.